Manorama Industries Limited has informed the Exchange about Transcript
MANORAMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Manorama Industries delivered exceptional FY26 performance with standalone revenue of INR 1,358 crores, up 76.1% YoY. EBITDA stood at INR 367.7 crores with 27.1% margin, while PAT reached INR 233.2 crores (17.2% margin). The company undertook 30% debottlenecking of its 25,000 ton solvent fractionation plant, taking total capacity to 47,500 tons. A strategic INR 460 crore capex program over 2-3 years includes a new 75,000 ton fractionation plant with CBA facility, additional refinery, and a backward integration project in Burkina Faso (~INR 120 crores) to reduce logistics costs and improve yields. Working capital improved to 125 days from 151 days. The company flagged a forex loss of INR 7.58 crores in Q4 due to mark-to-market provisions on hedged positions. Nine subsidiaries across Africa and LATAM are in early-stage operations, contributing to consolidated losses of INR 13.5 crores in their first year—described as transitional setup costs.
Strong operational performance with healthy cash generation (INR 259 crore operating cash flow) and improving return ratios (ROCE 33.6%, ROE 40.3%). Management guided for sustained 25%-27% EBITDA margins and 25%-30% revenue growth for FY27, driven by capacity utilization and value-added product mix (CBE now contributing 30% to revenues vs 10% two years ago).